Skip to Content

Darifenacin

In the US, Darifenacin (darifenacin systemic) is a member of the drug class urinary antispasmodics and is used to treat Overactive Bladder and Urinary Incontinence.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G04BD10

CAS registry number (Chemical Abstracts Service)

0133099-04-4

Chemical Formula

C28-H30-N2-O2

Molecular Weight

426

Therapeutic Categories

Spasmolytic agent

Muscarinic receptor antagonist (anticholinergic, parasympatholytic agent)

Urological

Chemical Names

(S)-1-[2-(2,3-dihydro-5-benzofuranyl)etyl]-α,α-diphenyl-3-pyrrolidineacetamide (WHO)

(S)-1-[2-(2,3-Dihydrobenzofuran-5-yl)etyl]-Õ,α-diphenylpyrrolidin-3-acetamid (IUPAC)

(S)-2-{1-[2-(2,3-Dihydrobenzo[b]furan-5-yl)etyl]pyrrolidin-3-yl}-2,2-diphenylacetamide (BAN)

Foreign Names

  • Darifenacinum (Latin)
  • Darifenacin (German)
  • Darifénacine (French)
  • Darifenacina (Spanish)

Generic Names

  • Darifenacin (OS: BAN, USAN)
  • Dasifenacin (IS)
  • UK 88525 (IS: Pfizer)
  • Darifenacin Hydrobromide (OS: BANM, USAN, JAN)
  • UK 88525-04 (IS: Pfizer)

Brand Names

  • Darifen-ER
    Acme, Bangladesh
  • Emselex
    Merus Labs, Norway; Novartis, Portugal
  • Enablex
    Novartis, Ecuador; Pharmacare, South Africa
  • Xelena
    Dr. Reddy's, India
  • Continex
    Baliarda, Argentina
  • Darisec
    Elea, Argentina
  • Emselex
    Bayer Vital, Germany; Futurus Pharma Oy, Finland; Merus, Denmark; Merus Labs, United Kingdom; Merz Pharma, Switzerland; Novartis, Belgium; Novartis, Czech Republic; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Iceland; Novartis, Lithuania; Novartis, Netherlands; Novartis, Serbia; Novartis, Sweden; Novartis, Slovenia; Novartis, Slovakia; Novartis, Turkey
  • Enablex
    Bagó, Argentina; Novartis, Colombia; Novartis, United States; Novartis Healthcare, Philippines; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada
  • Esmelex
    Merus Labs, Greece

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide